APA (7th ed.) Citation

Schram, A. M., Goto, K., Kim, D., Macarulla, T., Hollebecque, A., O'Reilly, E. M., . . . Springfeld, C. (2025). Efficacy of Zenocutuzumab in NRG1 Fusion-Positive Cancer. New England Journal of Medicine, 392(6), 566. https://doi.org/10.1056/NEJM022405008

Chicago Style (17th ed.) Citation

Schram, A. M., et al. "Efficacy of Zenocutuzumab in NRG1 Fusion-Positive Cancer." New England Journal of Medicine 392, no. 6 (2025): 566. https://doi.org/10.1056/NEJM022405008.

MLA (9th ed.) Citation

Schram, A. M., et al. "Efficacy of Zenocutuzumab in NRG1 Fusion-Positive Cancer." New England Journal of Medicine, vol. 392, no. 6, 2025, p. 566, https://doi.org/10.1056/NEJM022405008.